Our Experts

Joel Bradley, a PhD organic chemist from MIT, founded Cambridge Isotope Laboratories (CIL) in 1981. From the beginning, CIL's mission has been to drive the expansion of market applications of stable isotopes with innovative product development while providing the highest quality product and unsurpassed service to our customers.

Joel Bradley, a PhD organic chemist from MIT, founded Cambridge Isotope Laboratories (CIL) in 1981. From the beginning, CIL's mission has been to drive the expansion of market applications of stable isotopes with innovative product development while providing the highest quality product and unsurpassed service to our customers. Since 1981, CIL has worked with leading scientific groups in the fields of environmental ultratrace analysis, metabolic research, molecular biology, protein structure analysis, clinical and diagnostic research, who have turned to the use of stable isotopes in order to solve their most demanding problems.

Dr. Bradley and the CIL Executive Team all share the same commitment to quality and service.

Dr. William Wood, the Director of Chemistry, is responsible for manufacturing of research products, environmental standards and tandem mass spec standards standards. He holds a PhD from the University of London in synthetic organic chemistry.

William Wood, Director of Chemistry, is responsible for manufacturing of research products, environmental standards and neonatal screening standards. He holds a PhD from the University of London in synthetic organic chemistry, has over 30 years experience in the field and has published over 40 papers, patents and monographs. Outside of the laboratory, he is interested in choral music and composition.

Dr. Tim Eckersley, the Director of Quality Control, is responsible for the operation of the quality control laboratories for both regulated and accredited (GMP and ISO) and non-regulated manufacturing.

Dr. Tim Eckersley, Director of Quality Control, is responsible for the operation of the quality control laboratories for both regulated and accredited (GMP and ISO) and non-regulated manufacturing. He holds a PhD from the University of Lancaster (UK) in physical organic chemistry.

Tasha is currently holds the position as the Deuterated Reagents and Intermediates Product Manager, where she focuses her time working with companies on their stable isotope-labeled product needs for synthetic applications, including the manufacturing of APIs.

Krista is responsible for managing and promoting products that are utilized in Metabolomics and Clinical/Diagnostic MS. She spends a lot of her time developing new products to assist customers in their diverse research efforts.

Krista oversees all market development and promotional activities for CIL’s products with a focus in the metabolomics and clinical/diagnostic MS markets. She spends a lot of her time developing new products to assist customers in their diverse research efforts. She has been with CIL since 2005 and has held many different positions within the Sales and Marketing team since then. She has a BS in biology and biotechnology from Worcester Polytechnic Institute and an MBA with concentrations in health sector management and marketing from Boston University. In her free time, Krista likes to travel, cook, play soccer, and ride her bike!

Joel Louette joined Cambridge Isotope Laboratories in 2013 as the Director of European Business Development. In this role, Joel is responsible for rationalizing and developing the European market for CIL products.

Joel Louette joined Cambridge Isotope Laboratories in 2013 as the Director of European  Business Development. In this role, Joel is responsible for rationalizing and developing the European market for CIL products. Joel comes to CIL with more than 20 years of experience from Thermo Fisher Scientific where he held many roles including Commercial Director. Joel holds a Master's Degree in Biochemistry from the University of Leige in Belgium.

Ben Priest currently holds the position of Business Development Manager – Environmental Standards, where he is responsible for development of stable isotope labeled standards and standard mixtures to meet requirements of researchers, regulatory agencies and commercial testing laboratories worldwide. He is also responsible for development of key partnerships to develop standards for analysis of environmental, food, water, and human exposure samples.

Xinwen Zhou became the Business Development Director, responsible for the China market in 2015. He is responsible for Identifying and pursuing new opportunities for market expansion, developing the relationship with the key opinion leader in the field, supporting distributors to gain more share from the market, organizing/attending technical conferences to expand CIL's market footprint, building brand recognition in the Chinese market.

Xinwen Zhou became the Business Development Director, responsible for the China market in 2015. He is responsible for Identifying and pursuing new opportunities for market expansion, developing the relationship with the key opinion leader in the field, supporting distributors to gain more share from the market, organizing/attending technical conferences to expand CIL's market footprint, building brand recognition in the  Chinese market. 

Xinwen has been in the Mass Spectrometry field for more than 11 years, previously working as a District Sales Manager at Sciex before becoming a Market Development Manager, also at Sciex. 

Xinwen holds an MBA from Shanghai Jiaotong University as well as a Masters in Plant Biology from Zhejiang University.

Ros joined Cambridge Isotope Laboratories, Inc. in 2014 as the Business Development Manager. His focus is developing new business opportunities for CIL within the MRS/MRI, Metabolomics and GMP product lines.

Dr. Andrew Percy is the Senior Applications Chemist for Mass Spectrometry. His responsibilities minimally involve overseeing product development, identifying new product market opportunities, assisting in the analysis of products for MS ‘omics applications, and providing technical support to customers.

Dr. Andrew Percy is the Senior Applications Chemist for Mass Spectrometry. His responsibilities minimally involve overseeing product development, identifying new product market opportunities, assisting in the analysis of products for MS ‘omics applications, and providing technical support to customers.

Andrew has been in the MS field for more than 10 years. His main focus in his previous research was in the areas of structural and quantitative proteomics. In the former area, he developed several analytical methods to structurally interrogate binary multicomponent complexes (i.e., protein-ligand and protein-protein) through the use of novel bottom-up hydrogen/deuterium exchange mass spectrometric (H/DX-MS) approaches and novel data analysis strategies (e.g., minimalist and surogate approaches). In quantitative proteomics, he developed and applied an array of novel technologies for the targeted and multiplexed quantitation of candidate disease protein biomarkers in human/mouse biosamples. This research experimentally involved a bottom-up LC-MRM/MS approach with isotopically labeled peptide standards, while the analyzed biosamples encompassed invasive (e.g. human cerebrospinal fluid), minimally invasive (e.g. human/mouse plasma), and non-invasive (e.g. human urine and saliva) matrices. Overall, Dr. Percy has published more than 40 articles in peer-reviewed journals, acts on the editorial board of the Journal of Proteomics and Genomics, and serves as a regular ad-hoc review for a number of journals.

Kevin Millis, PhD, is the Senior Scientist and Market Development Manager for all NMR and Mass Spectrometry product lines. Kevin is responsible for Technical Services both internally and externally for all CIL customers as well as being responsible for the application and market development for the CIL products.

Kevin Millis, PhD, is the Senior Scientist and Application Development Manager. Kevin is responsible for technical services both internally and externally for all CIL customers, as well as being responsible for the application and market development for the CIL products.

Kevin has been with CIL for over 16 years holding many positions starting with QC test method development and regulatory affairs manager and working his way to market development, where he is currently responsible for building market position by locating, developing, defining, negotiating and closing business relationships. He was instrumental in bringing the manufacture and testing of the ¹⁸0 water into GMP compliance. 

Kevin holds a BS in chemistry, biochemistry emphasis, from California State University, Fullerton; an MS in analytical chemistry; and a PhD in analytical chemistry from the University of California, Riverside.